Menu Search
Equities

ECO Animal Health Group PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LWA:FRA

ECO Animal Health Group PLC

Actions
  • Price (EUR)1.18
  • Today's Change-0.04 / -3.28%
  • Shares traded500.00
  • 1 Year change+60.54%
  • Beta0.8154
Data delayed at least 15 minutes, as of Feb 10 2026 14:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

ECO Animal Health Group plc is a United Kingdom-based global animal health company. The Company is focused on improving the health and welfare of pigs and poultry. It is engaged in developing and marketing branded veterinary pharmaceuticals globally, in antibiotics and vaccines for pigs and poultry. The Company is focused on providing solutions to respiratory and enteric diseases in pigs and poultry. Its segment includes the United Kingdom, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World. It provides products for swine and poultry to treat illness, improving health and performance. The Company’s lead product, Aivlosin, is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. It also offers a range of products to treat parasites in cattle, sheep and pigs under the brand name Ecomectin.

  • Revenue in GBP (TTM)85.81m
  • Net income in GBP3.02m
  • Incorporated1984
  • Employees219.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.